|
1
|
Frost G: The latency period of
mesothelioma among a cohort of British asbestos workers
(1978–2005). Br J Cancer. 109:1965–1973. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Delgermaa V, Takahashi K, Park EK, Le GV,
Hara T and Sorahan T: Global mesothelioma deaths reported to the
World Health Organization between 1994 and 2008. Bull World Health
Organ. 89:716–724. 724A–724C. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murayama T, Takahashi K, Natori Y and
Kurumatani N: Estimation of future mortality from pleural malignant
mesothelioma in Japan based on an age-cohort model. Am J Ind Med.
49:1–7. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Joshi TK and Gupta RK: Asbestos in
developing countries: Magnitude of risk and its practical
implications. Int J Occup Med Environ Health. 17:179–185.
2004.PubMed/NCBI
|
|
5
|
Yap TA, Aerts JG, Popat S and Fennell DA:
Novel insights into mesothelioma biology and implications for
therapy. Nat Rev Cancer. 17:475–488. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mattick JS: The genetic signatures of
noncoding RNAs. PLoS Genet. 5:e10004592009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kapranov P, St Laurent G, Raz T, Ozsolak
F, Reynolds CP, Sorensen PH, Reaman G, Milos P, Arceci RJ, Thompson
JF, et al: The majority of total nuclear-encoded non-ribosomal RNA
in a human cell is ‘dark matter’ un-annotated RNA. BMC Biol.
8:1492010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gibb EA, Vucic EA, Enfield KS, Stewart GL,
Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S,
Brown CJ, et al: Human cancer long non-coding RNA transcriptomes.
PLoS One. 6:e259152011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brosnan CA and Voinnet O: The long and the
short of noncoding RNAs. Curr Opin Cell Biol. 21:416–425. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Statello L, Guo CJ, Chen LL and Huarte M:
Gene regulation by long non-coding RNAs and its biological
functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Costa FF: Non-coding RNAs: Meet thy
masters. BioEssays. 32:599–608. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huarte M and Rinn JL: Large non-coding
RNAs: Missing links in cancer? Hum Mol Genet. 19:R152–R161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui M, You L, Ren X, Zhao W, Liao Q and
Zhao Y: Long non-coding RNA PVT1 and cancer. Biochem Biophys
Res Commun. 471:10–14. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang D and Hu Y: Long Non-coding RNA
PVT1 Competitively Binds MicroRNA-424-5p to Regulate CARM1
in Radiosensitivity of Non-Small-Cell Lung Cancer. Mol Ther Nucleic
Acids. 16:130–140. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu J, Han Q, Gu Y, Ma J, McGrath M, Qiao
F, Chen B, Song C and Ge Z: Circular RNA PVT1 expression and
its roles in acute lymphoblastic leukemia. Epigenomics. 10:723–732.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo J, Hao C, Wang C and Li L: Long
noncoding RNA PVT1 modulates hepatocellular carcinoma cell
proliferation and apoptosis by recruiting EZH2. Cancer Cell Int.
18:982018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang R, Li J, Yan X, Jin K, Li W, Liu X,
Zhao J, Shang W and Liu Y: Long Noncoding RNA Plasmacytoma Variant
Translocation 1 (PVT1) Promotes Colon Cancer Progression via
Endogenous Sponging miR-26b. Med Sci Monit. 24:8685–8692. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guan Y, Kuo WL, Stilwell JL, Takano H,
Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, Santos JL, et al:
Amplification of PVT1 contributes to the pathophysiology of
ovarian and breast cancer. Clin Cancer Res. 13:5745–5755. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Q, Yu Y, Sun Z and Pan Y: Long
non-coding RNA PVT1 promotes cell proliferation and invasion
through regulating miR-133a in ovarian cancer. Biomed Pharmacother.
106:61–67. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kuraoka M, Amatya VJ, Kushitani K, Mawas
AS, Miyata Y, Okada M, Kishimoto T, Inai K, Nishisaka T, Sueda T,
et al: Identification of DAB2 and Intelectin-1 as Novel Positive
Immunohistochemical Markers of Epithelioid Mesothelioma by
Transcriptome Microarray Analysis for Its Differentiation From
Pulmonary Adenocarcinoma. Am J Surg Pathol. 41:1045–1052. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barretina J, Caponigro G, Stransky N,
Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV,
Sonkin D, et al: The Cancer Cell Line Encyclopedia enables
predictive modelling of anticancer drug sensitivity. Erratum.
Nature. 492:2902012. View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gebäck T, Schulz MM, Koumoutsakos P and
Detmar M: TScratch: A novel and simple software tool for automated
analysis of monolayer wound healing assays. Biotechniques.
46:265–274. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lamprecht MR, Sabatini DM and Carpenter
AE: CellProfiler: Free, versatile software for automated biological
image analysis. Biotechniques. 42:71–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Montanaro F, Rosato R, Gangemi M, Roberti
S, Ricceri F, Merler E, Gennaro V, Romanelli A, Chellini E,
Pascucci C, et al: Survival of pleural malignant mesothelioma in
Italy: A population-based study. Int J Cancer. 124:201–207. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao C, Tian D, Park J, Allan J, Pataky KA
and Yan TD: A systematic review and meta-analysis of surgical
treatments for malignant pleural mesothelioma. Lung Cancer.
83:240–245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bunch H: Gene regulation of mammalian long
non-coding RNA. Mol Genet Genomics. 293:1–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long Non-Coding RNA in the Pathogenesis of Cancers. Cells.
8:10152019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wright CM, Kirschner MB, Cheng YY, O'Byrne
KJ, Gray SG, Schelch K, Hoda MA, Klebe S, McCaughan B, van Zandwijk
N, et al: Long non coding RNAs (lncRNAs) are dysregulated in
Malignant Pleural Mesothelioma (MPM). PLoS One. 8:e709402013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Riquelme E, Suraokar MB, Rodriguez J, Mino
B, Lin HY, Rice DC, Tsao A and Wistuba II: Frequent coamplification
and cooperation between C-MYC and PVT1 oncogenes promote
malignant pleural mesothelioma. J Thorac Oncol. 9:998–1007. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang A, Wang H and Yang X: Long non-coding
RNA PVT1 indicates a poor prognosis of glioma and promotes
cell proliferation and invasion via target EZH2. Biosci Rep.
37:BSR201708712017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fei BY, He X, Ma J, Zhang M and Chai R:
FOXM1 is associated with metastasis in colorectal cancer
through induction of the epithelial-mesenchymal transition. Oncol
Lett. 14:6553–6561. 2017.PubMed/NCBI
|
|
37
|
Shi C and Zhang Z: MicroRNA-320 suppresses
cervical cancer cell viability, migration and invasion via directly
targeting FOXM1. Oncol Lett. 14:3809–3816. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang J, Chen XY, Huang KJ, Wu WD, Jiang
T, Cao J, Zhou LS, Qiu ZJ and Huang C: Expression of FOXM1
and the EMT-associated protein E-cadherin in gastric cancer and its
clinical significance. Oncol Lett. 12:2445–2450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tassi RA, Todeschini P, Siegel ER, Calza
S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera
E, et al: FOXM1 expression is significantly associated with
chemotherapy resistance and adverse prognosis in non-serous
epithelial ovarian cancer patients. J Exp Clin Cancer Res.
36:632017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang H, Zhong H, Li L, Ji W and Zhang X:
Overexpressed transcription factor FOXM1 contributes to the
progression of colorectal cancer. Mol Med Rep. 13:2696–2700. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang J, Niu Y and Huang C: Role of
FOXM1 in the Progression and Epithelial to Mesenchymal
Transition of Gastrointestinal Cancer. Recent Patents Anticancer
Drug Discov. 12:247–259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kong FF, Qu ZQ, Yuan HH, Wang JY, Zhao M,
Guo YH, Shi J, Gong XD, Zhu YL, Liu F, et al: Overexpression of
FOXM1 is associated with EMT and is a predictor of poor
prognosis in non-small cell lung cancer. Oncol Rep. 31:2660–2668.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li M, Chi C, Zhou L, Chen Y and Tang X:
Circular PVT1 regulates cell proliferation and invasion via
miR-149-5p/FOXM1 axis in ovarian cancer. J Cancer.
12:611–621. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xu MD, Wang Y, Weng W, Wei P, Qi P, Zhang
Q, Tan C, Ni SJ, Dong L, Yang Y, et al: A Positive Feedback Loop of
lncRNA-PVT1 and FOXM1 Facilitates Gastric Cancer
Growth and Invasion. Clin Cancer Res. 23:2071–2080. 2017.
View Article : Google Scholar : PubMed/NCBI
|
